# Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

> **NCT05711823** · PHASE3 · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Aprepitant in combination with granisetron and dexamethasone
- **DRUG:** Granisetron and dexamethasone

## Key facts

- **NCT ID:** NCT05711823
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711823, "Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05711823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*